HealthVerity + AWS: Pathways to success in AI – Webinar recap
With advances in artificial intelligence (AI) making headlines almost daily, the life sciences...
With advances in artificial intelligence (AI) making headlines almost daily, the life sciences...
An interview with Kristijan Kahler, executive director of innovation evidence at Novartis While...
Given its role at the intersection of novel real-world data and emerging technologies, HealthVerity...
Our series on how Privacy Preserving Record Linkage (PPRL) technology can help government agencies...
HealthVerity is proud to partner with Inovalon, the largest closed claims data source in the U.S.,...
In our ongoing series on how Privacy-Preserving Record Linkage (PPRL) technology can help...
Healthcare brand marketing is at a crossroads. With patients taking a more active role in their...
One in eight women in the U.S. will be diagnosed with breast cancer in their lifetime, that’s one...
In our series on how Privacy-Preserving Record Linkage (PPRL) technology can help government...
The use of real-world data has been gaining traction in the healthcare and life sciences...
Regulatory decision-making depends on evidence that reflects how medical products perform in real-world use, not only in controlled trials. For more than a decade, the Food and Drug Administration has relied on real-world data and real-world evidence...